Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography.


BACKGROUND Positron emission tomography (PET) with 18-F-fluorodeoxyglucose (FDG) has already proven useful in assessing the extension of esophageal carcinomas, detecting tumor recurrence and monitoring responses to therapy. The current study aims to assess the potential role of FDG-PET in predicting the response of esophageal squamous cell carcinoma (SCC… (More)


  • Presentations referencing similar topics